DRUG ADMINISTRATION: Can You Bill Concurrent Infusion For Two Drugs In One Bag?

Why This Topic Matters

Drug administration billing can vary by local carrier policy, so understanding where CMS defers to contractors helps avoid claim denials and inconsistent billing practices across regions. The article is useful for teams that need to track Medicare guidance affecting infusion and injection reporting.

Article Sections

1. CMS guidance on drug administration FAQ questions

   Introduces the CMS FAQ framework and explains that several drug administration billing questions may be addressed through local carrier policy. Covers the general policy context and why contractor guidance matters.

2. Carrier discretion for infusion and injection scenarios

   Discusses multiple billing scenarios involving infusion and injection administration, including concurrent and repeated services. Focuses on how CMS places certain decisions at the carrier level.

3. Commentary on local coverage determinations

   Summarizes commentary from industry sources about the likely impact of expanded local coverage determinations. Addresses the broader administrative implications for providers working in different states.

4. Chemotherapy administration FAQ clarification

   Covers CMS clarification on chemotherapy administration policy and the types of services discussed in the FAQ. Addresses the broader distinction between covered chemotherapy-related administration and other drug administration issues.